Latest news
Loading news…
OncoImmune
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Rockville, Maryland, United States Founded 2000 10001+ employees For Profit
OncoImmune is a clinical-stage biopharmaceutical company that develops solutions for the treatment of cancer.
OncoImmune was acquired by Merck in 2020 for $425M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
4,190
Patents
26
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Patents granted
- 26
- Trademarks
- 0
- Top patent class
- Organic Chemistry
- IT spend
- $1B
Company Info
- Founded
- 2000
- Employees
- 10001+
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 4
- News articles
- 56
- HQ
- Rockville, Maryland, United States
- Region
- Washington DC Metro Area, East Coast, Southern US
- Exit date
- Nov 23, 2020
Signals & Scores
- Heat score
- Low
- Trend (7d)
- -0.3
- Trend (30d)
- -0.7
- Trend (90d)
- 2.1
4,190
professional contacts at OncoImmune
Contact execs at OncoImmune →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to OncoImmune
Loading news…
FAQs about OncoImmune
People who checked this page also checked these
Browse the full Acquirezy directory.